President, Cell Therapy Organization
Bristol Myers Squibb
Lynelle Hoch
Lynelle Hoch is president, Cell Therapy Organization, leading Bristol Myers Squibb’s cross-functional cell therapy business since June 2021. In this role, she oversees the teams responsible for the research, development, manufacturing and commercialization of BMS’ marketed and pipeline cell therapies, united in the shared mission of unlocking the full potential of cell therapy and putting patients on the path to a cure.
Since starting her career as an engineer intern in manufacturing, Lynelle has held increasingly senior positions at BMS over the last 25+ years in sales, marketing and market access, both internationally and in the U.S. Prior to joining the cell therapy business, Lynelle was the general manager for BMS in the UK and Ireland, where she grew the company’s presence as well as its ability to deliver innovative medicines to patients. Before that, Lynelle successfully led the marketing organization for the immuno-oncology portfolio and worked with teams across therapeutic areas and functions.
Lynelle earned a BS in geoenvironmental engineering from The Pennsylvania State University.
Since starting her career as an engineer intern in manufacturing, Lynelle has held increasingly senior positions at BMS over the last 25+ years in sales, marketing and market access, both internationally and in the U.S. Prior to joining the cell therapy business, Lynelle was the general manager for BMS in the UK and Ireland, where she grew the company’s presence as well as its ability to deliver innovative medicines to patients. Before that, Lynelle successfully led the marketing organization for the immuno-oncology portfolio and worked with teams across therapeutic areas and functions.
Lynelle earned a BS in geoenvironmental engineering from The Pennsylvania State University.
